Nevertheless, TMEM170B expression was not significantly associated with sex, age, tumor size or number, pathological tumor-node-metastasis (pTNM) stage, pT classification, serum carcinoembryonic antigen, and carbohydrate antigen 19–9 (CA19-9) levels (Table 1). This evidence concerns the gene CEACAM5 and neoplasm.